Nopmanee Taechangam, DVM, PhD
Principal Scientist at Gallant
Dr. Nopmanee Taechangam, DVM, PhD, joined Gallant in 2021 and serves as a Principal Scientist specializing in veterinary regenerative medicine and stem cell therapy. A Fulbright scholar, she earned her PhD in Integrative Pathobiology from UC Davis, where her research focused on mesenchymal stem cell therapies for immune-mediated and infectious diseases in animals.
Dr. Taechangam has developed and validated multiple FDA-accepted potency assays for investigational veterinary cell therapies, supporting regulatory approval and product quality standards. Her work focuses on advancing safe, effective, off-the-shelf stem cell therapies for pets at scale.
All published content
Science Library
Journal Articles
Feline adipose-derived mesenchymal stem cells induce effector phenotype and enhance cytolytic function of CD8+ T cells
Read more
Science Library
Journal Articles
Mechanisms utilized by feline adipose-derived mesenchymal stem cells to inhibit T lymphocyte proliferation
Read more
